Patent · US Active

Bifidobacterium longum able to beneficially modulate immune response to respiratory virus infection

US11590179B2 · kind B2 · utility

0Cited by

2References

5Claims

0Family size

Assignee

PrecisionBiotics Group Limited · IE

Inventors

Barry Kiely · Cork, IE
Liam O'Mahony · Cork, IE
David GROEGER · Cork, IE

Key dates

Filing date	Feb 28, 2018
Grant date	Feb 28, 2023
Priority date	—
Expiry date	Feb 28, 2038

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12R2001/01
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Bifidobacterium longum strains and cell wall fractions isolated from Bifidobacterium longum strains are useful in the prophylaxis or treatment of a respiratory viral infection in a subject. They are also useful in the prophylaxis of a secondary bacterial infection associated with a respiratory viral infection in a subject, especially a subject who is susceptible to respiratory infections.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.